U.S. Veterinary Surgical Instruments Market Size & Share 2026-2035
Market Size By Product (Sutures and staplers, Forceps, Scalpels, Surgical scissors, Hooks and retractors, Trocars and cannulas, Electro-surgery instruments, Other products), By Animal Type (Companion animals, Livestock animals, Exotic and zoo animals), By Application (Soft tissue surgery, Sterilization surgery, Dental surgery, Orthopedic surgery, Ophthalmic surgery, Other applications), By End Use (Veterinary hospitals, Veterinary clinics, Academic and research institutes, Other end users). The market forecasts are provided in terms of value (USD).
Download Free PDF

U.S. Veterinary Surgical Instruments Market Size
The U.S. veterinary surgical instruments market was valued at USD 598.9 million in 2025. The market is estimated to grow from USD 626.4 million in 2026 to USD 1.1 billion in 2035, growing at a CAGR of 6.2% from 2026 to 2035, as per the latest report published by Global Market Insights Inc.
U.S. Veterinary Surgical Instruments Market Key Takeaways
Market Size & Growth
Regional Dominance
Key Market Drivers
Challenges
Opportunity
Key Players
Rapidly growing population of both pet and livestock animals in the country coupled with high expenditure on animal healthcare and veterinary services are some of the major factors driving the U.S. market growth.
Veterinary surgical instruments are handheld tools that include forceps, sutures and staplers, towel clamps, a scalpel handle (and blade), a needle holder, and other instruments, used primarily by veterinarians and surgeons to perform surgical procedures on animals.
Key players include Vimian Group, B. Braun Vet Care, Ethicon, Integra LifeSciences, and Jorgensen Laboratories. These companies play a critical role in advancing the market by providing high-quality and precision tools, enabling minimally invasive and complex surgical procedures, and supporting improved surgical outcomes through innovation, durability, and integration of advanced surgical technologies.
Pet ownership in the U.S. has jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. Of these, 97% of pet owners consider their pets to be a part of their family. As per the data published by the American Pet Products Association (2023-2024), in 2022, Americans spent approximately USD 136.8 billion on their pets, up nearly 11% from 2021 (USD 123.6 billion). Similarly, the country is also home to a large population of livestock animals. For example, the U.S. is home to approximately 87.1 million cattle and calves as of 2024 and around 74.1 million hogs and pigs. Such a high population of animals in the country and high expenditure on animal care drive the demand for various veterinary healthcare services, including surgeries, thereby propelling the market growth.
Furthermore, the growing incidence of several chronic diseases in animals, such as cancer, osteoarthritis, hip and joint issues, and cardiovascular diseases, increases the demand for effective treatments, such as surgeries, further driving the market growth. For instance, as per a study published by the National Institute of Health (NIH), osteoarthritis prevalence in North America is reported to be 20% of all dogs over 1 year of age based on data collected from 200 veterinarians. Similarly, data suggests that in the U.S., about 14 million adult dogs are affected by osteoarthritis, making it a top health concern for owners. In addition, partnerships among veterinary clinics, hospitals, and surgical instrument producers are growing more prevalent. These collaborations provide access to specialized instruments, further increasing access to advanced surgical instruments.
The U.S. market demonstrated steady growth between 2022 and 2024, driven by rising pet ownership, increasing veterinary procedures, and higher spending on animal healthcare. The market was valued at approximately USD 532.3 million in 2022, grew to around USD 552.3 million in 2023, and reached about USD 574.3 million in 2024, reflecting consistent year-on-year growth. This upward trajectory is supported by the growing prevalence of chronic conditions in companion animals, advancements in surgical techniques, and the expansion of veterinary clinics and specialty hospitals across the U.S. market.
U.S. Veterinary Surgical Instruments Market Trends
U.S. Veterinary Surgical Instruments Market Analysis
Based on the product, the U.S. market is segmented into sutures and staplers, forceps, scalpels, surgical scissors, hooks and retractors, trocars and cannulas, electro-surgery instruments, and other products. The sutures and staplers segment dominated the market in 2025 and was valued at USD 143.3 million.
Based on the animal type, the U.S. veterinary surgical instruments market is categorized into companion animals, livestock animals, and exotic and zoo animals. The companion animals segment dominated the market with 61.1% market share in 2025. The segment includes dogs, cats, horses, and other companion animals.
Based on the application, the U.S. veterinary surgical instruments market is categorized into soft tissue surgery, sterilization surgery, dental surgery, orthopedic surgery, ophthalmic surgery, and other applications. The soft tissue surgery segment dominated the market and is anticipated to reach USD 355.1 million by 2035.
Based on the end use, the U.S. veterinary surgical instruments market is classified into veterinary hospitals, veterinary clinics, academic and research institutes, and other end users. In 2025, the veterinary hospitals segment held the highest market share and is expected to showcase growth at 6.1% CAGR over the analysis period.
The South Atlantic zone dominated the U.S. veterinary surgical instruments market with a market share of 22.8% in 2025.
The Florida veterinary surgical instruments market was valued at USD 39.6 million and USD 40.6 million in 2022 and 2023, respectively. The market size reached USD 43 million in 2025, growing from USD 41.7 million in 2024.
Georgia veterinary surgical instruments market is anticipated to witness considerable growth over the analysis period.
Pacific Central zone of the U.S. was valued at USD 100.8 million in 2025 and is anticipated to witness significant growth over the analysis period.
East North Central zone of the U.S. is poised for high growth in the veterinary surgical instruments market.
U.S. Veterinary Surgical Instruments Market Share
The U.S. market is highly fragmented, with the presence of both established players and new emerging companies, along with several local players focusing on innovation and technological advancements. The prominent players operating in the veterinary surgical instrument industry include Vimian Group, B. Braun Vet Care, Integra LifeSciences, Ethicon, and Jorgensen Laboratories, among others. These top 5 market players hold 42% of the U.S. market share. These companies offer comprehensive portfolios that include sutures, forceps, scalpels, and advanced electrosurgical tools, addressing a wide range of surgical requirements in veterinary practices. Their commitment to innovation and quality has been instrumental in setting industry standards and meeting the evolving demands of veterinary professionals.
In addition to these larger players, the market also comprises specialized companies such as Sklar Surgical Instruments and GerMedUSA, which focus on niche segments and offer tailored solutions for veterinary surgeries. These firms often emphasize product customization and close collaboration with veterinary practitioners to develop instruments that meet specific clinical needs. The competitive environment is further intensified by strategic initiatives like mergers and acquisitions; for instance, Vimian Group's acquisition of iM3 in 2024 expanded its presence in the veterinary dental instruments sector, while Patterson Veterinary's acquisition of Mountain Vet Supply in 2024 enhanced its distribution capabilities. Such activities underscore the market's dynamic nature, driven by the increasing demand for advanced surgical instruments in veterinary medicine.
U.S. Veterinary Surgical Instruments Market Companies
Major players operating in the U.S. veterinary surgical instruments industry are:
B. Braun Vet Care is a prominent player in the U.S. market, offering a comprehensive range of high-quality tools under its Aesculap brand. The company provides over 6,000 surgical instruments, including specialized sets for procedures like soft tissue surgery and cat castration, catering to diverse veterinary needs. In 2018, B. Braun Vet Care expanded its North American presence by partnering with CP Medical to distribute its veterinary products in the U.S. and Canada. B. Braun's commitment to innovation and quality continues to make it a trusted name among veterinary professionals.
Vimian Group is a prominent player in the U.S. market, leveraging its MedTech segment (including surgical and orthopedic solutions) to support advanced veterinary procedures. The company operates across over 80 markets and serves thousands of veterinary clinics, with the U.S. representing a key revenue contributor, highlighting its strong footprint in the region. Vimian’s growth strategy focuses on acquiring niche animal health companies and integrating innovative technologies, enabling it to expand its surgical instrument portfolio and strengthen its competitive position in the U.S. market.
~14.5% market share
Collective market share is ~42%
U.S. Veterinary Surgical Instruments Industry News
The U.S. veterinary surgical instruments market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Animal Type
Market, By Application
Market, By End Use
The above information is provided for the following zones and states:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →